Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-19-041809
Filing Date
2019-07-25
Accepted
2019-07-25 14:05:47
Documents
49
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 6-K a19-12893_16k.htm 6-K 4166890
8 GRAPHIC g128931bci001.jpg GRAPHIC 2500
  Complete submission text file 0001104659-19-041809.txt   21356072

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT azn-20190630.xml EX-101.INS 7298806
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT azn-20190630.xsd EX-101.SCH 64728
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT azn-20190630_cal.xml EX-101.CAL 68562
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT azn-20190630_def.xml EX-101.DEF 189520
6 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT azn-20190630_lab.xml EX-101.LAB 436673
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT azn-20190630_pre.xml EX-101.PRE 357861
Mailing Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA
Business Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA 011 44 20 7304 5000
ASTRAZENECA PLC (Filer) CIK: 0000901832 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-11960 | Film No.: 19973781
SIC: 2834 Pharmaceutical Preparations